IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383,351 | -7.5% | 39,808 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $414,641 | -1.5% | 38,970 | -2.6% | 0.00% | -25.0% |
| Q1 2023 | $420,821 | -12.7% | 40,002 | +2.8% | 0.00% | -20.0% |
| Q4 2022 | $482,144 | +23.6% | 38,914 | +3.4% | 0.01% | +25.0% |
| Q3 2022 | $390,000 | -12.9% | 37,625 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $448,000 | -15.3% | 38,834 | -7.6% | 0.00% | 0.0% |
| Q1 2022 | $529,000 | +8.8% | 42,025 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $486,000 | -11.2% | 41,651 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $547,000 | +2.2% | 41,913 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $535,000 | +8.1% | 41,566 | -6.1% | 0.00% | 0.0% |
| Q1 2021 | $495,000 | -1.4% | 44,274 | +0.5% | 0.00% | -20.0% |
| Q4 2020 | $502,000 | +22.1% | 44,074 | -3.5% | 0.01% | +25.0% |
| Q3 2020 | $411,000 | +17.4% | 45,685 | +34.7% | 0.00% | -20.0% |
| Q2 2020 | $350,000 | -5.7% | 33,923 | -7.9% | 0.01% | -16.7% |
| Q1 2020 | $371,000 | – | 36,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,597,065 | $72,510,000 | 15.06% |
| SOUND ENERGY PARTNERS, INC. | 400,566 | $5,189,000 | 4.02% |
| SECTOR GAMMA AS | 1,138,291 | $14,747,000 | 3.45% |
| Orbimed Advisors | 12,012,100 | $155,617,000 | 1.62% |
| SHAPIRO ROBERT N | 485,974 | $6,296,000 | 1.20% |
| Broderick Brian C | 166,345 | $2,156,000 | 0.96% |
| Hall Kathryn A. | 193,588 | $2,508,000 | 0.65% |
| Tekla Capital Management LLC | 768,050 | $9,950,000 | 0.47% |
| PARADIGM ASSET MANAGEMENT CO LLC | 180,800 | $2,342,264,000 | 0.33% |
| BOURGEON CAPITAL MANAGEMENT LLC | 42,800 | $554,000 | 0.32% |